Reviews in Endocrine & Metabolic Disorders

Papers
(The H4-Index of Reviews in Endocrine & Metabolic Disorders is 33. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review168
Replacement with sex steroids in hypopituitary men and women: implications for gender differences in morbidities and mortality164
Pathophysiological insights into asprosin: an emerging adipokine in reproductive health118
Predictors of incident diabetic peripheral neuropathy: a systematic review of longitudinal studies in patients with diabetes mellitus112
Insulin icodec: A novel once-weekly formulation for the treatment of type 1 and type 2 diabetes mellitus93
Patient and health care provider knowledge of diabetes and diabetic microvascular complications: a comprehensive literature review91
Traumatic brain injury and prolactin79
New drugs for the treatment of obesity: do we need approaches to preserve muscle mass?79
Effectiveness and safety of continuous subcutaneous hydrocortisone infusion in managing adrenocortical insufficiency in adult patients: a systematic review69
The genetics of Graves’ disease60
Endocrine responses of the stress system to different types of exercise60
Application of radiomics and machine learning to thyroid diseases in nuclear medicine: a systematic review58
Epigenetic programming for obesity and noncommunicable disease: From womb to tomb52
Diagnostic and prognostic utility of phase angle in patients with cancer49
Advances in the management of anaplastic thyroid carcinoma: transforming a life-threatening condition into a potentially treatable disease46
Prolactin deficiency in the context of other pituitary hormone abnormalities45
Posttranslational modifications in diabetes: Mechanisms and functions45
Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic43
Preface43
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease42
Central and peripheral regulation of the GH/IGF-1 axis: GHRH and beyond42
Androgens, aging, and prostate health42
Mention to Prof. Andrew V. Schally41
Cancer screening in patients with acromegaly: a plea for a personalized approach and international registries41
Hypothalamic GHRH41
A multifaceted and inclusive methodology for the detection of sarcopenia in patients undergoing bariatric surgery: an in-depth analysis of current evidence40
Deep neural network for food image classification and nutrient identification: A systematic review38
Polycystic ovary syndrome and risks for COVID-19 infection: A comprehensive review38
Neurovascular plasticity as a modulator of hypothalamic function37
The diagnosis and management of pheochromocytoma and paraganglioma during pregnancy36
No longer to be ignored: Hypophosphatemia following intravenous iron administration35
Appetitive interoception, the hippocampus and western-style diet35
Preoperative systemic inflammatory markers as prognostic factors in differentiated thyroid cancer: a systematic review and meta-analysis35
The bidirectional relationship of thyroid disease and atrial fibrillation: Established knowledge and future considerations33
Correction: Hypothalamic GHRH33
Towards precision medicine in non-alcoholic fatty liver disease33
The uprise of RNA biology in neuroendocrine neoplasms: altered splicing and RNA species unveil translational opportunities33
Ciliopathies are responsible for short stature and insulin resistance: A systematic review of this clinical association regarding SOFT syndrome33
0.038932800292969